-
The next health boom after Ozempic? Inside the world of self-injectable pens
-
Industry estimates suggest between 25 and 30 million people worldwide have used GLP-1 receptors. The rise in popularity and curiosity is down to “a once-weekly dosing schedule, the ease of administration at home and the promising results over a short time”, says Dr Bhanu Malhotra, specialist endocrinologist, RAK Hospital. They have also helped to reduce a fear of needles, she adds.
This widespread awareness and use have led many other health and wellness companies to optimise the same formats, making home injection pens even more commonplace.
